PharmaShots | Incisive News in 3 Shots

Subscribe Now

FDA Fast Track Designation

Genascence Corporation’s GNSC-001 Receives the US FDA’s Fast Track Designation for Treating Osteoarthritis (OA) of the Knee

Genascence Corporation’s GNSC-001 Receives the US FDA’s Fast Track Designation for Treating Osteoarthritis (OA) of the Knee

November 14, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us